Search research articles
Contact Us
Filters
Showing results (81-90 of 183) with videos related to
Page
of 19
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
September 18, 2024
Transdifferentiation occurs without resetting development-specific DNA methylation, a key determinant of full-function cell identity
Ahmed Radwan, Jason Eccleston, Ofra Sabag, et al.
Science Advances
|
September 7, 2019
A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling
Duc-Huy T Nguyen, Esak Lee, Styliani Alimperti, et al.
Molecular Cell
|
April 3, 2026
The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer
Maimon E Hubbi, Catherine L Wang, Yasir Suhail, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
May 8, 2020
Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma
Christopher A Natale, Jinyang Li, Jason R Pitarresi, et al.
Gastroenterology
|
September 15, 2012
Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice
Augusto Villanueva, Clara Alsinet, Kilangsungla Yanger, et al.
Cell Reports. Medicine
|
December 9, 2020
Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer
Wells S Brown, Paul C McDonald, Oksana Nemirovsky, et al.
Cancer Discovery
|
April 23, 2025
Intrinsic properties of the lymph node render it immunologically susceptible to metastasis
Benjamin M Kahn, Raymond W S Ng, Il-Kyu Kim, et al.
Molecular Cancer Research : MCR
|
October 1, 2021
MYC Hyperactivates Wnt Signaling in <i>APC</i>/<i>CTNNB1</i>-Mutated Colorectal Cancer Cells through miR-92a-Dependent Repression of <i>DKK3</i>
Priyanka Sehgal, Claudia Lanauze, Xin Wang, et al.
Cancer Research
|
October 8, 2013
Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance
Yaqing Zhang, Wei Yan, Meredith A Collins, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
Quantitative MRI Measurements Capture Pancreatic Cancer and Stroma Reactions to New KRAS Inhibitor
Mamta Gupta, Hoon Choi, Samantha B Kemp, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 183) with videos related to
Sort By:
Page
of 19
Proceedings of the National Academy of Sciences of the United States of America
|
September 18, 2024
Transdifferentiation occurs without resetting development-specific DNA methylation, a key determinant of full-function cell identity
Ahmed Radwan, Jason Eccleston, Ofra Sabag, et al.
Science Advances
|
September 7, 2019
A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling
Duc-Huy T Nguyen, Esak Lee, Styliani Alimperti, et al.
Molecular Cell
|
April 3, 2026
The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer
Maimon E Hubbi, Catherine L Wang, Yasir Suhail, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
May 8, 2020
Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma
Christopher A Natale, Jinyang Li, Jason R Pitarresi, et al.
Gastroenterology
|
September 15, 2012
Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice
Augusto Villanueva, Clara Alsinet, Kilangsungla Yanger, et al.
Cell Reports. Medicine
|
December 9, 2020
Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer
Wells S Brown, Paul C McDonald, Oksana Nemirovsky, et al.
Cancer Discovery
|
April 23, 2025
Intrinsic properties of the lymph node render it immunologically susceptible to metastasis
Benjamin M Kahn, Raymond W S Ng, Il-Kyu Kim, et al.
Molecular Cancer Research : MCR
|
October 1, 2021
MYC Hyperactivates Wnt Signaling in <i>APC</i>/<i>CTNNB1</i>-Mutated Colorectal Cancer Cells through miR-92a-Dependent Repression of <i>DKK3</i>
Priyanka Sehgal, Claudia Lanauze, Xin Wang, et al.
Cancer Research
|
October 8, 2013
Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance
Yaqing Zhang, Wei Yan, Meredith A Collins, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
Quantitative MRI Measurements Capture Pancreatic Cancer and Stroma Reactions to New KRAS Inhibitor
Mamta Gupta, Hoon Choi, Samantha B Kemp, et al.
Page
of 19